S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Shares to be sold to cover withholding taxes upon vesting of restricted stock unit award

Date of Notice

03/03/2025

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Stephen Rodin, as Attorney-in-Fact

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Aadi Bioscience (NASDAQ:AADI)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Aadi Bioscience Charts.

Aadi Bioscience (NASDAQ:AADI)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Aadi Bioscience Charts.

Aadi Bioscience Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 March 2025 (14 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 March 2025 (14 hours ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 4 March 2025 (14 hours ago) • Edgar (US Regulatory)

Aadi Bioscience Announces Approval of All Proposals at Special Meeting of Stockholders
Tuesday 4 March 2025 (1 day ago) • PR Newswire (US)

Aadi Bioscience to Present at the TD Cowen 45th Annual Healthcare Conference
Tuesday 25 February 2025 (1 week ago) • PR Newswire (US)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Thursday 20 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 19 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Wednesday 19 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer
Wednesday 19 February 2025 (2 weeks ago) • PR Newswire (US)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 15 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Thursday 6 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025
Thursday 6 February 2025 (4 weeks ago) • PR Newswire (US)

More Aadi Bioscience Inc News Articles

BNP Paribas Issuance

BNP Paribas Issuance

Vontobel Financial Produ...

Infrastructure Wireless ...

Mrs Logistica ON

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions